Translation Regulation as a Therapeutic Target in Cancer
The DOI matches its Crossref record; 141 of the 145 references it cites were found in a registry or an index.
Abstract
Protein synthesis is a vital cellular process that regulates growth and metabolism. It is controlled via signaling networks in response to environmental changes, including the presence of nutrients, mitogens, or starvation. The phosphorylation state of proteins involved in translation initiation is a limiting factor that regulates the formation or activity of translational complexes. In cancer cells, hyperactivated signaling pathways influence translation, allowing uncontrolled growth and survival. In addition, several components of translation initiation have been found to be mutated, posttranslationally modified, or differentially expressed, and some act as oncogenes in cancer cells. Translational alterations can increase the overall rate of protein synthesis as well as activate regulatory mechanisms leading to the translation of specific messenger RNAs for proteins that promote cancer progression and survival. Many recent studies investigating such mechanisms have produced ideas for therapeutic intervention. This review describes altered mechanisms of protein synthesis in human cancers and discusses therapeutic approaches based on the targeting of translation. Cancer Res; 72(16); 3891–900. ©2012 AACR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
2 retracted
Shi, Y., Yan, H., Frost, P., Gera, J., & Lichtenstein, A. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0068 · Cited by 368
RetractedMarzec, M., Liu, X., Wysocka, M., Rook, A. H., Ødum, N., & Wasik, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024849 · Cited by 53
RetractedGlobal quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Self-citationAMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
Sonenberg, N., & Hinnebusch, A. G. (2009) · Cell · doi:10.1016/j.cell.2009.01.042 · Cited by 3,304
Regulation of mRNA Translation and Stability by microRNAs
Fabian, M. R., Sonenberg, N., & Filipowicz, W. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060308-103103 · Cited by 3,214
The mechanism of eukaryotic translation initiation and principles of its regulation
Jackson, R. J., Hellen, C. U. T., & Pestova, T. V. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2838 · Cited by 2,759
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,114
Research works printed but not linked: 1
- Smith, 1990, Translation initiation factors induce DNA synthesis and transform NIH 3T3 cells, New Biol, 2, 648
Cited by
A census of human RNA-binding proteins
Gerstberger, S., Hafner, M., & Tuschl, T. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3813 · Cited by 2,032
“inhibiting the translation initiation factors EIF4A1 and 2 (Grzmil and Hemmings, 2012; Hein et al., 2013; Silvera et al., 2010; Skrtić et al., 2011).”
BackgroundRibosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance
Elhamamsy, A. R., Metge, B. J., Alsheikh, H. A., Shevde, L. A., & Samant, R. S. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4087 · Cited by 300
Inhibition of mTORC1 by Astrin and Stress Granules Prevents Apoptosis in Cancer Cells
Thedieck, K., Holzwarth, B., Prentzell, M. T., Boehlke, C., Kläsener, K., Ruf, S., Sonntag, A. G., Maerz, L., Grellscheid, S.-N., Kremmer, E., et al. (2013) · Cell · doi:10.1016/j.cell.2013.07.031 · Cited by 336
“…reading frames (uORF) and internal ribosomal entry sites (IRES) (Holcik and Sonenberg, 2005). mTORC1 induces both IRES-mediated (Dai et al., 2011; Grzmil and Hemmings, 2012) and uORF-dependent translation (Ramı́rez-Valle et al., 2008), and both mTORC1 and SGs control translation of stress…”
Proteogenomic data and resources for pan-cancer analysis
Li, Y., Dou, Y., Da Veiga Leprevost, F., Geffen, Y., Calinawan, A. P., Aguet, F., Akiyama, Y., Anand, S., Birger, C., Cao, S., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.06.009 · Cited by 249
Wang, T., Cui, Y., Jin, J., Guo, J., Wang, G., Yin, X., He, Q.-Y., & Zhang, G. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt178 · Cited by 210
“Relevant to our study, it has been well known that hyper-activation of multiple signalling pathways in cancer cells results in global upregulation of translation [reviewed in (49)].”
Background
Metadata
- Authors
- Grzmil, M., & Hemmings, B. A.
- Affiliations
- Friedrich Miescher Institute (CH)
- Corresponding author
- Grzmil, Michal
- ORCID
- Grzmil, Michal
- Venue
- Cancer Research
- Published
- 2012-08-14
- Volume
- 72
- Issue
- 16
- Pages
- 3891-3900
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2106016335
- Cited by
- 103
- References
- 145
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 6 · 2022: 7 · 2021: 11 · 2020: 9 · 2019: 6 · 2018: 6 · 2017: 8 · 2016: 10 · 2015: 8 · 2014: 9 · 2013: 12 · 2012: 2
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Social Sciences › Arts and Humanities › Language and Linguistics › Translation Studies and Practices
- Keywords
- translational regulation, cancer, protein synthesis, translation initiation, oncogenes, post-translational modification, therapeutic targeting, tumor progression, tumor cell survival
- MeSH terms
- Humans, Neoplasm Proteins, Neoplasms, Protein Biosynthesis, Signal Transduction, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Translation Regulation as a Therapeutic Target in Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-12-0026
- The paper
- Grzmil, M., & Hemmings, B. A. (2012). Translation Regulation as a Therapeutic Target in Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-12-0026
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.